Quantitative Measurement of Cationic Polymer Vector and Polymer–pDNA Polyplex Intercalation into the Cell Plasma Membrane
Source abstract
Abstract
Cationic gene delivery agents (vectors) are important for delivering nucleotides, but are also responsible for cytotoxicity. Cationic polymers (L-PEI, jetPEI, and G5 PAMAM) at 1× to 100× the concentrations required for translational activity (protein expression) induced the same increase in plasma membrane current of HEK 293A cells (30-50 nA) as measured by whole cell patch-clamp. This indicates saturation of the cell membrane by the cationic polymers. The increased currents induced by the polymers are not reversible for over 15 min. Irreversibility on this time scale is consistent with a polymer-supported pore or carpet model and indicates that the cell is unable to clear the polymer from the membrane. For polyplexes, although the charge concentration was the same (at N/P ratio of 10:1), G5 PAMAM and jetPEI polyplexes induced a much larger current increase (40-50 nA) than L-PEI polyplexes (<20 nA). Both free cationic lipid and lipid polyplexes induced a lower increase in current than cationic polymers (<20 nA). To quantify the membrane bound material, partition constants were measured for both free vectors and polyplexes into the HEK 293A cell membrane using a dye influx assay. The partition constants of free vectors increased with charge density of the vectors. Polyplex partition constants did not show such a trend. The long lasting cell plasma permeability induced by exposure to the polymer vectors or the polyplexes provides a plausible mechanism for the toxicity and inflammatory response induced by exposure to these materials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Departments of Biomedical Engineering, ‡Chemistry, and §Physics, and ∥the Programs in Applied Physics and ⊥Biophysics, University of Michigan, Ann Arbor, Michigan 48109, United States
Funding
National Institute of Biomedical Imaging and Bioengineering
References (52)
Show source-provided references
1. Nguyen J. · Acc. Chem. Res. · 2012 · 45 · 115310.1021/ar3000162 ↗
2. Mintzer M. A. · Chem. Rev. · 2009 · 109 · 25910.1021/cr800409e ↗
3. Wang A. Z. · Annu. Rev. Med. · 2012 · 63 · 18510.1146/annurev-med-040210-162544 ↗
4. Leroueil P. R. · Nano Lett. · 2008 · 8 · 42010.1021/nl0722929 ↗
5. Lin J. · ACS Nano · 2010 · 4 · 542110.1021/nn1010792 ↗
6. Arvizo R. R. · Nano Lett. · 2010 · 10 · 254310.1021/nl101140t ↗
7. Huhn D. · ACS Nano · 2013 · 7 · 325310.1021/nn3059295 ↗
8. Hong S. · Bioconjugate Chem. · 2006 · 17 · 72810.1021/bc060077y ↗
9. Moghimi S. M. · Mol. Ther. · 2005 · 11 · 99010.1016/j.ymthe.2005.02.010 ↗
10. Grandinetti G. · Mol. Pharmaceutics · 2012 · 9 · 52310.1021/mp200368p ↗
11. Grandinetti G. · Mol. Pharmaceutics · 2011 · 8 · 170910.1021/mp200078n ↗
12. Matz R. L. · Mol. Pharmaceutics · 2013 · 10 · 130610.1021/mp300470d ↗
13. Hong S. · Bioconjugate Chem. · 2004 · 15 · 77410.1021/bc049962b ↗
14. Erickson B. · Langmuir · 2008 · 24 · 1100310.1021/la801497d ↗
15. Chen J. · J. Phys. Chem. B · 2009 · 113 · 1117910.1021/jp9033936 ↗
16. Mecke A. · Biophys. J. · 2005 · 89 · 404310.1529/biophysj.105.062596 ↗
17. Mecke A. · Langmuir · 2005 · 21 · 1034810.1021/la050629l ↗
18. Lee H. · J. Phys. Chem. B · 2008 · 112 · 1227910.1021/jp805026m ↗
19. Lee H. · Molecules · 2009 · 14 · 42310.3390/molecules14010423 ↗
20. Lee H. · J. Phys. Chem. B · 2008 · 112 · 777810.1021/jp802606y ↗
21. Lee H. · J. Phys. Chem. B · 2006 · 110 · 1820410.1021/jp0630830 ↗
22. Kelly C. V. · J. Phys. Chem. B · 2008 · 112 · 933710.1021/jp801377a ↗
23. Kelly C. V. · J. Phys. Chem. B · 2008 · 112 · 934610.1021/jp8013783 ↗
24. Yan L.-T. · ACS Nano · 2009 · 3 · 217110.1021/nn9004236 ↗
25. Nyitrai G. · Biochim. Biophys. Acta · 2013 · 1828 · 187310.1016/j.bbamem.2013.04.004 ↗
26. Zhou Y. · Ultrasound Med. Biol. · 2009 · 35 · 175610.1016/j.ultrasmedbio.2009.05.012 ↗
27. Rattan R. · Mol. Pharmaceutics · 2013 · 10 · 301310.1021/mp400103f ↗
28. Prevette L. E. · Mol. Pharmaceutics · 2012 · 9 · 274310.1021/mp3002864 ↗
29. Heerklotz H. · Biophys. J. · 2000 · 78 · 243510.1016/S0006-3495(00)76787-7 ↗
30. Lichtenberg D. · Trends Biochem. Sci. · 2013 · 38 · 8510.1016/j.tibs.2012.11.005 ↗
31. Lasch J. · Biochim. Biophys. Acta, Rev. Biomembr. · 1995 · 1241 · 26910.1016/0304-4157(95)00010-O ↗
32. Heerklotz H. · Q. Rev. Biophys. · 2008 · 41 · 20510.1017/S0033583508004721 ↗
33. Preté P. S. C. · Biophys. Chem. · 2002 · 97 · 110.1016/S0301-4622(02)00043-1 ↗
34. Preté P. S. C. · Biophys. Chem. · 2002 · 97 · 4510.1016/S0301-4622(02)00042-X ↗
35. Preté P. S. C. · Biochim. Biophys. Acta, Biomembr. · 2011 · 1808 · 16410.1016/j.bbamem.2010.10.016 ↗
36. Heerklotz H. · Eur. Biophys. J. · 2007 · 36 · 30510.1007/s00249-006-0091-5 ↗
37. Heerklotz H. · Biochim. Biophys. Acta · 2000 · 1508 · 6910.1016/S0304-4157(00)00009-5 ↗
38. De la Maza A. · Biochem. J. · 1994 · 303 · 90710.1042/bj3030907 ↗
39. De la Maza A. · J. Controlled Release · 1998 · 52 · 15910.1016/S0168-3659(97)00205-8 ↗
40. Tan A. · Biophys. J. · 2002 · 83 · 154710.1016/S0006-3495(02)73924-6 ↗
41. Beck A. · J. Phys. Chem. B · 2010 · 114 · 1586210.1021/jp107088d ↗
42. Vaidyanathan S. · J. Phys. Chem. B · 2014 · 118 · 211210.1021/jp4124315 ↗
43. Lichtenberg D. · Biochim. Biophys. Acta, Biomembr. · 2000 · 1508 · 110.1016/S0304-4157(00)00004-6 ↗
44. Cócera M. · Langmuir · 2004 · 20 · 307410.1021/la035972+ ↗
45. Van Dongen M. A. · J. Phys. Chem. B · 2014 · 118 · 719510.1021/jp504059p ↗
46. Mullen D. G. · Macromolecules · 2012 · 45 · 531610.1021/ma300485p ↗
47. Prevette L. E. · Mol. Pharmaceutics · 2010 · 7 · 87010.1021/mp100027g ↗
48. Kim S. T. · Acc. Chem. Res. · 2013 · 46 · 68110.1021/ar3000647 ↗
49. Dougherty C. A. · Chem.—Eur. J. · 2014 · 20 · 463810.1002/chem.201304854 ↗
50. Dougherty C. A. · Bioconjugate Chem. · 2015 · 26 · 30410.1021/bc5005735 ↗
51. Spencer C. I. · Assay Drug Dev. Technol. · 2012 · 10 · 31310.1089/adt.2011.414 ↗
52. Alberts B. · 2002